24.4 C
London, UK
Tuesday, 02, June, 2020

Tag: ketamine

John Read – UK Esketamine Approval – Not so Fast

An interview with Professor John Read who joins us to discuss the UK licensing of esketamine nasal spray (Spravato) for so-called ‘Treatment Resistant Depression’. John led a group of 12 academics and professionals who wrote to the UK regulator expressing concerns.

Are Our Regulatory Bodies Prioritising Drug Company Interests Over Public Safety?

The UK’s Medicines & Healthcare Products Regulatory Agency is refusing to respond to the concerns of psychiatrists, parliamentarians, patients and other experts about the impending licensing of the street drug ketamine as a treatment for depression.

Ketamine Antidepressant Could Bring Opioid-like Addiction Risks, Study Warns

From The Independent. Ketamine-based treatments for severe depression could further fuel the addiction epidemic sweeping the US, researchers have warned, after a new study found the drug...